Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Biome Australia Ltd ( (AU:BIO) ).
Biome Australia Ltd has issued 1,000,000 fully paid ordinary shares upon the exercise of options, expanding its share capital without providing a prospectus-level disclosure to new investors. The company confirmed it remains compliant with its financial reporting and continuous disclosure obligations and stated there is no withheld price-sensitive information that investors would reasonably require to assess the company or the rights attached to the new shares.
By lodging the required notice under section 708A(5) of the Corporations Act, Biome ensures that these newly issued shares can be freely traded on the secondary market without additional disclosure. The move clarifies regulatory status for market participants and supports liquidity in the company’s securities while signalling that management sees no undisclosed issues affecting Biome’s financial position or shareholder rights.
The most recent analyst rating on (AU:BIO) stock is a Hold with a A$0.42 price target. To see the full list of analyst forecasts on Biome Australia Ltd stock, see the AU:BIO Stock Forecast page.
More about Biome Australia Ltd
Biome Australia Ltd is an ASX-listed company operating in the health and wellness sector. It issues fully paid ordinary shares under ticker BIO as part of its capital management and incentive structures in the Australian market.
Average Trading Volume: 254,710
Technical Sentiment Signal: Sell
Current Market Cap: A$86.82M
For a thorough assessment of BIO stock, go to TipRanks’ Stock Analysis page.